Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01292096 · ClinicalTrials.gov registry record · Phase 1

Intervening With and Improving Care for Patients at Risk for Frequent Hospital Admissions

A Phase 1 study, sponsored by NYU Langone Health.

Completed
Registry status
Phase 1
Development phase
19
Enrollment target

NCT01292096 is a Phase 1 study that has completed, run by NYU Langone Health. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01292096, a Phase 1 study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
Phase 1
Development phase
19 participants
Enrollment target

Study Summary

Patients with frequent hospital admissions account for a disproportionate share of visits and costs. An intervention that can bridge the gap between hospital and community based care for a population of patients with frequent hospital admissions may offer both improved care and cost savings if hospital admissions can be appropriately reduced. We are now using data from our previous research to inform the development and implementation of an intervention at Bellevue Hospital, which will bridge the gap between hospital and community based care for a population of patients with frequent hospital admissions. We hypothesize that such an intervention can offer both improved care and cost savings if hospital admissions can be appropriately reduced. In this protocol we outline a strategy to pilot a small-scale intervention on a small subset of patients admitted to an urban public tertiary care safety net hospital who are defined by our study criteria as at high risk for future readmission. By piloting components of the intervention, we aim to assure the intervention functions as planned, and can deliver the needed services to high risk patients in a seamless and patient-centered manner. The purpose of this "feasibility study" is to ensure that when our intervention is implemented on a larger scale, it appropriately serves enrolled patients needs, and that we are able to effectively follow patients during the intervention period.

Interventions

  • OTHER Provision of extra (care coordination and management) services

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2007-08
Est. Completion 2009-03
Phase Phase 1

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT01292096

The ClinicalTrials.gov registry entry for NCT01292096 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Provision of extra (care coordination and management) services is the first listed.

NCT01292096 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01292096 about?

NCT01292096 is a clinical study titled "Intervening With and Improving Care for Patients at Risk for Frequent Hospital Admissions". Patients with frequent hospital admissions account for a disproportionate share of visits and costs. An intervention that can bridge the gap between hospital and community based care for a population of patients with frequent hospital admissions may offer both improved care and cost savings if hospi...

What is the current status of trial NCT01292096?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2007-08. Estimated completion is 2009-03.

What interventions are being tested in trial NCT01292096?

The interventions under investigation include: Provision of extra (care coordination and management) services (OTHER).

Who is sponsoring clinical trial NCT01292096?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.